Abstract

The prevalence of pre-diabetes (PD) and type II diabetes (T2D) has risen dramatically in recent years affecting an estimated 422 million adults worldwide. The risk of T2D increases with age, with the sharpest rise in diagnosis occurring after age 40. With age, there is also a progressive decline in muscle mass starting after the age of 30. The decline in muscle mass and function due to aging is termed sarcopenia and immediately precedes the sharp rise in T2D. The purpose of the current review is to discuss the role of protein to attenuate declines in muscle mass and insulin sensitivity to prevent T2D and sarcopenia in aging adults. The current recommended dietary allowance for protein consumption is set at 0.8 g/kg/day and is based on dated studies on young healthy men and may not be sufficient for older adults. Protein consumption upwards of 1.0–1.5 g/kg/day in older adults is able to induce improvements in glycemic control and muscle mass. Obesity, particularly central or visceral obesity is a major risk factor in the development of PD and T2D. However, the tissue composition of weight loss in older adults includes both lean body mass and fat mass and therefore may have adverse metabolic consequences in older adults who are already at a high risk of lean body mass loss. High protein diets have the ability to increase weight loss while preserving lean body mass therefore inducing “high-quality weight loss,” which provides favorable metabolic changes in older adults. High protein diets also induce beneficial outcomes on glycemic markers due to satiety, lowered post-prandial glucose response, increased thermogenesis, and the ability to decrease rates of muscle protein breakdown (MPB). The consumption of dairy specific protein consumption has also been shown to improve insulin sensitivity by improving body composition, enhancing insulin release, accelerating fat oxidation, and stimulating rates of muscle protein synthesis (MPS) in older adults. Exercise, specifically resistance training, also works synergistically to attenuate the progression of PD and T2D by further stimulating rates of MPS thereby increasing muscle mass and inducing favorable changes in glycemic control independent of lean body mass increases.

Highlights

  • The average lifespan has increased by 20 years, increasing the age of the population worldwide [1]

  • With age there is a loss of muscle mass and the development of insulin resistance (IR), increasing the risk of sarcopenia and T2D

  • Protein has emerged as a potential strategy to combat the decline in muscle mass and insulin sensitivity (IS) that occur with increasing age, potentially preventing the development of T2D and sarcopenia

Read more

Summary

INTRODUCTION

The average lifespan has increased by 20 years, increasing the age of the population worldwide [1]. Approximately one third of adults over the age of 50 are not meeting the protein RDA, with a staggering 35% of older adults in institutional care who are not meeting the estimated average requirement (EAR), which is the minimum intake level of protein to maintain proper muscle integrity [43, 48], which may be affecting their overall health and disease risk Lifestyle management such as a healthy diet has long been recommended to improve glycemic control, it is not certain what dietary approach is best for individuals with diabetes with most recommendations centered around individualized needs based on glycemic control, age, and co-morbidities [44]. These positive outcomes are thought to be due to several mechanisms, including an increase in protein anabolism, weight loss, enhanced glycemic control, daily appetite control, and satiety [47, 58] (Figure 2)

Protein Intake and Its Effect on Insulin Sensitivity and Glycemic Control
Findings
CONCLUSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call